Fragile X Syndrome
Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people, and is a result of mutation associated with the gene FMR1.
DelveInsight's newsletter series brings to light an overview of Fragile X syndrome, underlying causes, risk factors, etiology, and symptoms.
The newsletter provides a brief scenario of the prevalence and incidence of the disease, present treatment approaches and the therapies and drugs in the pipeline for the disease. The newsletter also covers the present market scenario and the companies that are working to shift the Fragile X syndrome market in the coming decade with key collaborations, and partnerships along with top conferences that are going to take place in the following year.
However, the analysis of the Cancer epidemiological trends by the American Cancer Society revealed a drop in the mortality rate due to cancer. The reduction in death rate could be due to increased awareness among people, better lifestyle habits and a better understanding of the tumour and its treatment.
Download our newsletter by filling up the form and gain access to deep and rich insights into Fragile X syndrome market.
Want analytical information related to Rare Diseases directly delivered to your inbox? Join DelveInsight's emailer list and gain a competitive edge.
Stay tuned for more.
Know more about What's covered:
- Indication overview
- Treatment approaches
- Pipeline drugs
- Key Companies
- Support from International organizations